Evidence map›Paper›PMID 15028761›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2004

A nonsense mutation of the sodium channel gene SCN2A in a patient with intractable epilepsy and mental decline.

Kazusaku Kamiya, Makoto Kaneda, Takashi Sugawara, Emi Mazaki, Nami Okamura, Mauricio Montal, Naomasa Makita, Masaki Tanaka, Katsuyuki Fukushima, Tateki Fujiwara and 2 more

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 90 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
90citing papers in PubMed, 1 pooled it
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

90 citing papers in PubMed, 1 synthesis or guideline pooled it, 193 citations in OpenAlex.

  1. Genetic polymorphisms in SCN2A are not associated with epilepsy risk and AEDs response: evidence from a meta-analysis.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2021
    Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. DecipheringArXiv · 2024
    Article
  8. Article
  9. Distinctive In Vitro Phenotypes in iPSC-Derived Neurons From Patients With Gain- and Loss-of-FunctionThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2024
    Article
  10. Article
  11. International journal of molecular sciences · 2023
    Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review

30 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Kazusaku KamiyaLaboratory for Neurogenetics, RIKEN Brain Science Institute, Saitama 351-0198, Japan.
Makoto Kaneda
Takashi Sugawara
Emi Mazaki
Nami Okamura
Mauricio Montal
Naomasa Makita
Masaki Tanaka
Katsuyuki Fukushima
Tateki Fujiwara
Yushi Inoue
Kazuhiro Yamakawa
RIKEN Center for Brain Science · JPNational Epilepsy Center · JPHokkaido University · JPKeio University · JPUniversity of California, San Diego · US

Funding

Modular Design of Voltage-Gated Channel ProteinsR01GM049711 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MONTAL, MAURICIO S · 1993 to 2017
$4.2M
NIGMS NIH HHS GM-49711NIGMS NIH HHS R01 GM049711
6 · The paper itself

Abstract

Mutations, exclusively missense, of voltage-gated sodium channel alpha subunit type 1 (SCN1A) and type 2 (SCN2A) genes were reported in patients with idiopathic epilepsy: generalized epilepsy with febrile seizures plus. Nonsense and frameshift mutations of SCN1A, by contrast, were identified in intractable epilepsy: severe myoclonic epilepsy in infancy (SMEI). Here we describe a first nonsense mutation of SCN2A in a patient with intractable epilepsy and severe mental decline. The phenotype is similar to SMEI but distinct because of partial epilepsy, delayed onset (1 year 7 months), and absence of temperature sensitivity. A mutational analysis revealed that the patient had a heterozygous de novo nonsense mutation R102X of SCN2A. Patch-clamp analysis of Na(v)1.2 wild-type channels and the R102X mutant protein coexpressed in human embryonic kidney 293 cells showed that the truncated mutant protein shifted the voltage dependence of inactivation of wild-type channels in the hyperpolarizing direction. Analysis of the subcellular localization of R102X truncated protein suggested that its dominant negative effect could arise from direct or indirect cytoskeletal interactions of the mutant protein. Haploinsufficiency of Na(v)1.2 protein is one plausible explanation for the pathology of this patient; however, our biophysical findings suggest that the R102X truncated protein exerts a dominant negative effect leading to the patient's intractable epilepsy.

Indexed as

AdultAutistic DisorderCell LineCodon, NonsenseDNA Mutational AnalysisElectroencephalographyEpilepsyFemaleGene ExpressionGenes, DominantHumansHyperkinesisIntellectual DisabilityKidneyNAV1.2 Voltage-Gated Sodium ChannelNerve Tissue ProteinsCodon, NonsenseNAV1.2 Voltage-Gated Sodium ChannelNerve Tissue ProteinsProtein SubunitsSCN2A protein, humanSodium Channels

Identifiers

PMID15028761
PMCPMC6729532
OpenAlexW2096680774

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.